Reaction Details |
| Report a problem with these data |
Target | Alpha-1B adrenergic receptor |
---|
Ligand | BDBM50118703 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_34200 (CHEMBL649217) |
---|
Ki | 2900±n/a nM |
---|
Citation | Altenbach, RJ; Khilevich, A; Meyer, MD; Buckner, SA; Milicic, I; Daza, AV; Brune, ME; O'Neill, AB; Gauvin, DM; Cain, JC; Nakane, M; Holladay, MW; Williams, M; Brioni, JD; Sullivan, JP N-[3-(1H-imidazol-4-ylmethyl)phenyl]ethanesulfonamide (ABT-866, 1),(1) a novel alpha(1)-adrenoceptor ligand with an enhanced in vitro and in vivo profile relative to phenylpropanolamine and midodrine. J Med Chem45:4395-7 (2002) [PubMed] |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Alpha-1B adrenergic receptor |
---|
Name: | Alpha-1B adrenergic receptor |
Synonyms: | ADA1B_HUMAN | ADRA1B | Adrenergic alpha1B | Adrenergic receptor | Adrenergic receptor alpha | Alpha 1B-adrenoceptor | Alpha 1B-adrenoreceptor | Alpha-1B adrenergic receptor |
Type: | Enzyme |
Mol. Mass.: | 56862.13 |
Organism: | Homo sapiens (Human) |
Description: | P35368 |
Residue: | 520 |
Sequence: | MNPDLDTGHNTSAPAHWGELKNANFTGPNQTSSNSTLPQLDITRAISVGLVLGAFILFAI
VGNILVILSVACNRHLRTPTNYFIVNLAMADLLLSFTVLPFSAALEVLGYWVLGRIFCDI
WAAVDVLCCTASILSLCAISIDRYIGVRYSLQYPTLVTRRKAILALLSVWVLSTVISIGP
LLGWKEPAPNDDKECGVTEEPFYALFSSLGSFYIPLAVILVMYCRVYIVAKRTTKNLEAG
VMKEMSNSKELTLRIHSKNFHEDTLSSTKAKGHNPRSSIAVKLFKFSREKKAAKTLGIVV
GMFILCWLPFFIALPLGSLFSTLKPPDAVFKVVFWLGYFNSCLNPIIYPCSSKEFKRAFV
RILGCQCRGRGRRRRRRRRRLGGCAYTYRPWTRGGSLERSQSRKDSLDDSGSCLSGSQRT
LPSASPSPGYLGRGAPPPVELCAFPEWKAPGALLSLPAPEPPGRRGRHDSGPLFTFKLLT
EPESPGTDGGASNGGCEAAADVANGQPGFKSNMPLAPGQF
|
|
|
BDBM50118703 |
---|
n/a |
---|
Name | BDBM50118703 |
Synonyms: | CHEMBL109783 | N-[5-(4,5-Dihydro-1H-imidazol-2-yl)-2-hydroxy-5,6,7,8-tetrahydro-naphthalen-1-yl]-methanesulfonamide |
Type | Small organic molecule |
Emp. Form. | C14H19N3O3S |
Mol. Mass. | 309.384 |
SMILES | CS(=O)(=O)Nc1c(O)ccc2C(CCCc12)C1=NCCN1 |t:18| |
Structure |
|